EP0674528A4 - Cyclodextrine et systeme de liberation de medicament a base de polymere. - Google Patents
Cyclodextrine et systeme de liberation de medicament a base de polymere.Info
- Publication number
- EP0674528A4 EP0674528A4 EP94902482A EP94902482A EP0674528A4 EP 0674528 A4 EP0674528 A4 EP 0674528A4 EP 94902482 A EP94902482 A EP 94902482A EP 94902482 A EP94902482 A EP 94902482A EP 0674528 A4 EP0674528 A4 EP 0674528A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cyclodextrin
- delivery system
- drug delivery
- polymer based
- based drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US984445 | 1992-12-02 | ||
| US07/984,445 US5332582A (en) | 1990-06-12 | 1992-12-02 | Stabilization of aminosteroids for topical ophthalmic and other applications |
| US15516793A | 1993-11-19 | 1993-11-19 | |
| US155167 | 1993-11-19 | ||
| PCT/US1993/011651 WO1994012217A1 (fr) | 1992-12-02 | 1993-12-01 | Cyclodextrine et systeme de liberation de medicament a base de polymere |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0674528A1 EP0674528A1 (fr) | 1995-10-04 |
| EP0674528A4 true EP0674528A4 (fr) | 1996-06-26 |
Family
ID=26852057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP94902482A Withdrawn EP0674528A4 (fr) | 1992-12-02 | 1993-12-01 | Cyclodextrine et systeme de liberation de medicament a base de polymere. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0674528A4 (fr) |
| JP (1) | JPH08503951A (fr) |
| CN (1) | CN1103316A (fr) |
| AU (1) | AU672862B2 (fr) |
| CA (1) | CA2150554A1 (fr) |
| WO (1) | WO1994012217A1 (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW434023B (en) * | 1995-09-18 | 2001-05-16 | Novartis Ag | Preserved ophthalmic composition |
| JP3940209B2 (ja) * | 1996-11-14 | 2007-07-04 | 株式会社資生堂 | 可溶化化粧料 |
| GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| US6656456B2 (en) | 1998-11-23 | 2003-12-02 | The Procter & Gamble Company | Skin deodorizing compositions |
| CN1328443A (zh) * | 1998-11-23 | 2001-12-26 | 宝洁公司 | 皮肤除臭和卫生消毒组合物 |
| JP2003529567A (ja) * | 2000-03-10 | 2003-10-07 | インサイト・ビジョン・インコーポレイテッド | 後眼部眼疾患を治療および予防する方法と組成物 |
| SI1278549T1 (sl) | 2000-05-02 | 2009-04-30 | Theravance Inc | Sestavek, ki vsebuje ciklodekstrin in glikopeptidni antibiotik |
| WO2001083520A2 (fr) | 2000-05-02 | 2001-11-08 | Theravance,Inc | Derives polyacides de glycopeptides |
| US6872804B2 (en) | 2000-06-22 | 2005-03-29 | Theravance, Inc. | Glycopeptide disulfide and thioester derivatives |
| UA75083C2 (uk) | 2000-06-22 | 2006-03-15 | Тераванс, Інк. | Похідні глікопептидфосфонатів |
| ES2302733T3 (es) | 2000-06-22 | 2008-08-01 | Theravance, Inc. | Derivados carboxi-sacaridos de glucopeptido. |
| AU2001259816A1 (en) | 2000-06-22 | 2002-01-02 | Advanced Medecine, Inc. | Polyhydroxy glycopeptide derivatives |
| JP4860895B2 (ja) * | 2000-09-26 | 2012-01-25 | 日清ファルマ株式会社 | リン酸プレドニゾロンナトリウム液体製剤 |
| CA2445606A1 (fr) * | 2001-05-11 | 2002-11-21 | Pacific Pharmaceuticals Limited | Composition pharmaceutique destinee a masquer le gout de certains medicaments |
| EP1621199B8 (fr) * | 2003-04-18 | 2011-01-19 | Advanced Medicine Research Institute | Remedes a des affections, a usage ophtalmique |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| WO2006040839A1 (fr) * | 2004-10-15 | 2006-04-20 | Advanced Medicine Research Institute | Gouttes oculaires et trousses de traitement de maladies oculaires |
| JP2007177149A (ja) * | 2005-12-28 | 2007-07-12 | Shield Lab:Kk | チオクト酸又はジヒドロリポ酸と分岐鎖シクロデキストリンとの包接化合物 |
| US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
| US20100311738A1 (en) * | 2007-12-21 | 2010-12-09 | Aop Orphan Pharmaceuticals Ag | Pharmaceutical Composition For The Parenteral Administration Of Ultrashort-Effective Beta-Adrenoreceptor Antagonists |
| US10980818B2 (en) | 2009-03-06 | 2021-04-20 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| US10201548B2 (en) * | 2009-03-06 | 2019-02-12 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| CN103327939B (zh) | 2010-10-15 | 2017-05-24 | 科尼尔赛德生物医学公司 | 用于进入眼睛的装置 |
| KR20150083117A (ko) | 2012-11-08 | 2015-07-16 | 클리어사이드 바이오메디컬, 인코포레이드 | 인간 대상체에서 안구 질병을 치료하기 위한 방법 및 장치 |
| WO2014127020A1 (fr) * | 2013-02-12 | 2014-08-21 | Ys Pharmtech | Formulations d'épinéphrine pour produits médicinaux |
| CN110302004B (zh) | 2013-05-03 | 2023-04-28 | 科尼尔赛德生物医学公司 | 用于眼部注射的设备和方法 |
| US10010447B2 (en) | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
| CN103990137A (zh) * | 2014-04-30 | 2014-08-20 | 福建融和药业有限公司 | 一种粘膜粘附性聚合物眼用药物的缓释剂 |
| EP3413851B1 (fr) | 2016-02-10 | 2023-09-27 | Clearside Biomedical, Inc. | Emballage |
| CA3062845A1 (fr) | 2016-05-02 | 2017-11-09 | Clearside Biomedical, Inc. | Systemes et methodes pour l'administration de medicaments par voie ophtalmique |
| US10973681B2 (en) | 2016-08-12 | 2021-04-13 | Clearside Biomedical, Inc. | Devices and methods for adjusting the insertion depth of a needle for medicament delivery |
| CN109136177B (zh) * | 2018-08-03 | 2021-09-17 | 湖南大学 | 一种***缓释体系以及一种成骨分化诱导液和应用 |
| RU2740287C1 (ru) * | 2019-08-30 | 2021-01-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | 3д-матриксная структура для доставки лекарственных препаратов |
| CN115380899A (zh) * | 2022-08-30 | 2022-11-25 | 陕西科技大学 | 一种凝胶型腐植酸缓释农药及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0300526A2 (fr) * | 1987-07-01 | 1989-01-25 | Janssen Pharmaceutica N.V. | Compositions pharmaceutiques antivirales contenant des cyclodextrines |
| EP0399716A1 (fr) * | 1989-05-24 | 1990-11-28 | Innovet, Inc. | Composition hypoallergénique stéroide à activité anesthésiante/hypnotique |
| EP0463653A1 (fr) * | 1990-06-07 | 1992-01-02 | PHARMACIA S.p.A. | Formulations galéniques contenant des cyclodextrines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4383992A (en) * | 1982-02-08 | 1983-05-17 | Lipari John M | Water-soluble steroid compounds |
| US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
| IE63392B1 (en) * | 1988-02-08 | 1995-04-19 | Insite Vision Inc | Ophthalmic suspensions |
-
1993
- 1993-12-01 JP JP6513478A patent/JPH08503951A/ja active Pending
- 1993-12-01 WO PCT/US1993/011651 patent/WO1994012217A1/fr not_active Application Discontinuation
- 1993-12-01 AU AU56841/94A patent/AU672862B2/en not_active Ceased
- 1993-12-01 EP EP94902482A patent/EP0674528A4/fr not_active Withdrawn
- 1993-12-01 CA CA002150554A patent/CA2150554A1/fr not_active Abandoned
- 1993-12-02 CN CN93120402A patent/CN1103316A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0300526A2 (fr) * | 1987-07-01 | 1989-01-25 | Janssen Pharmaceutica N.V. | Compositions pharmaceutiques antivirales contenant des cyclodextrines |
| EP0399716A1 (fr) * | 1989-05-24 | 1990-11-28 | Innovet, Inc. | Composition hypoallergénique stéroide à activité anesthésiante/hypnotique |
| EP0463653A1 (fr) * | 1990-06-07 | 1992-01-02 | PHARMACIA S.p.A. | Formulations galéniques contenant des cyclodextrines |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO9412217A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08503951A (ja) | 1996-04-30 |
| CA2150554A1 (fr) | 1994-06-09 |
| AU672862B2 (en) | 1996-10-17 |
| EP0674528A1 (fr) | 1995-10-04 |
| WO1994012217A1 (fr) | 1994-06-09 |
| AU5684194A (en) | 1994-06-22 |
| CN1103316A (zh) | 1995-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0674528A4 (fr) | Cyclodextrine et systeme de liberation de medicament a base de polymere. | |
| US5525634B1 (en) | Colonic drug delivery system | |
| EP0662851A4 (fr) | Systeme d'administration de medicaments. | |
| AU664807B2 (en) | Drug delivery system | |
| AU3127697A (en) | Intravenous catheter and delivery system | |
| IL117706A0 (en) | Powdered drug storage and delivery system | |
| AU4989993A (en) | Drug delivery system | |
| ZA988203B (en) | Aerosol medication delivery apparatus and system. | |
| AU3204995A (en) | Closed drug delivery system | |
| EP0643976A3 (fr) | Dispositif d'administration cardioplégique. | |
| AU9617698A (en) | Polymeric systems for drug delivery and uses thereof | |
| EP0647133A4 (fr) | Compositions et procedes destines a ameliorer la liberation et l'acheminement de medicaments. | |
| ZA967502B (en) | Medicament delivery device. | |
| AU7676894A (en) | Convection-enhanced drug delivery | |
| AU3290397A (en) | Gastric-retentive oral controlled drug delivery system with enhanced retention properties | |
| ZA965931B (en) | Transcorneal drug delivery system. | |
| ZA918526B (en) | Drug delivery system and method | |
| AU4406793A (en) | Water-soluble polymeric carriers for drug delivery | |
| EP0671165A3 (fr) | Système injectable pour la délivrance d'un médicament à base de collagène et son utilisation. | |
| AU1719800A (en) | Drug delivery systems and methods | |
| EP0648239A4 (fr) | Conjugues polymeres biocompatibles. | |
| EP0702966A3 (fr) | Systèmes de délivrance d'un produit de contraste avec dosage spécifique au patient et méthodes | |
| AU4468197A (en) | Hyaluronic drug delivery system | |
| AU660290B2 (en) | Multiple drug delivery system | |
| AU3481497A (en) | Chitosan drug delivery system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19950529 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19960509 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 19980202 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19980813 |